Therefore, more studies with sufficient sample size in men and women separately are needed to examine the feasibility of targeting RBP4 through these pharmacological and lifestyle interventions to reduce the risk of type 2 diabetes in high-risk populations. This evidence concerns the gene RBP4 and type 2 diabetes mellitus.